🔗 Share this article Individuals Discontinuing Anti-Obesity Medications Put On Pounds at a Quadrupled Rate Than Dieters Obesity treatment involves long-term strategies. A recent study suggests that people who come off new weight-loss injections like Wegovy and Mounjaro may regain shed pounds far faster than those who stop traditional diet and exercise regimens. Findings released in a prominent medical journal demonstrates that while obese people can lose a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month after stopping. "People purchasing these drugs need to be cognizant of the potential of rapid weight regain when the therapy concludes," cautioned expert Dr. Susan Jebb. This pace of regain means a reversion to starting weight within about one and a half years. Comparing Therapies The study, which examined 37 of studies involving thousands of participants, compared the effects of the injectable medications with conventional dieting. The team note that individuals who shed pounds through lifestyle changes alone generally have a more gradual creep back—perhaps 0.1 kg a month—after stopping. The Reason for the Quick Rebound Nutrition scientists propose the mechanism of the drugs accounts for the accelerated regain. The injections imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness. "Sustained high doses of GLP-1 concentrations far above than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher. "Withdrawal of this GLP-1 'fix' leads to appetite is uncontrolled, making excessive eating much more probable." A Chronic Disease? The NHS suggest the jabs for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications. A number of clinicians contend that, considering the likelihood of weight regain, the therapy is often ongoing. This opinion is supported by drug manufacturers, who note that the findings "emphasize the chronic nature of excess weight," akin to managing conditions like hypertension. Patient Testimonies People who have come off the medication explain a intense resurgence of hunger. "It was like something that goes on and you become starving," recalled one woman. This difficulty is worsened if individuals have not established sustainable lifestyle or habit modifications during therapy. Widespread Adoption Figures suggest that a significant number of people in the UK have used these injections in the past year, with demand continuing to grow. Adoption is greater among women than males. The 40s and 50s age group shows the highest usage rates. A large proportion access the medications through private healthcare rather than public health services. Ultimately, researchers emphasize that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic fix and long-term success relies on ongoing lifestyle management.
Obesity treatment involves long-term strategies. A recent study suggests that people who come off new weight-loss injections like Wegovy and Mounjaro may regain shed pounds far faster than those who stop traditional diet and exercise regimens. Findings released in a prominent medical journal demonstrates that while obese people can lose a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of nearly a kilo each month after stopping. "People purchasing these drugs need to be cognizant of the potential of rapid weight regain when the therapy concludes," cautioned expert Dr. Susan Jebb. This pace of regain means a reversion to starting weight within about one and a half years. Comparing Therapies The study, which examined 37 of studies involving thousands of participants, compared the effects of the injectable medications with conventional dieting. The team note that individuals who shed pounds through lifestyle changes alone generally have a more gradual creep back—perhaps 0.1 kg a month—after stopping. The Reason for the Quick Rebound Nutrition scientists propose the mechanism of the drugs accounts for the accelerated regain. The injections imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness. "Sustained high doses of GLP-1 concentrations far above than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition researcher. "Withdrawal of this GLP-1 'fix' leads to appetite is uncontrolled, making excessive eating much more probable." A Chronic Disease? The NHS suggest the jabs for people with obesity-related medical conditions, accompanied by prescribed diet and exercise modifications. A number of clinicians contend that, considering the likelihood of weight regain, the therapy is often ongoing. This opinion is supported by drug manufacturers, who note that the findings "emphasize the chronic nature of excess weight," akin to managing conditions like hypertension. Patient Testimonies People who have come off the medication explain a intense resurgence of hunger. "It was like something that goes on and you become starving," recalled one woman. This difficulty is worsened if individuals have not established sustainable lifestyle or habit modifications during therapy. Widespread Adoption Figures suggest that a significant number of people in the UK have used these injections in the past year, with demand continuing to grow. Adoption is greater among women than males. The 40s and 50s age group shows the highest usage rates. A large proportion access the medications through private healthcare rather than public health services. Ultimately, researchers emphasize that while GLP-1 drugs are powerful agents for shedding pounds, they are not a magic fix and long-term success relies on ongoing lifestyle management.